Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against infectious salmon anemia (ISA) and subsequent ISA virus infection
-
Published source details
Lauscher A., Krossoy B., Frost P., Grove S., Konig M. & Bohlin J. (2011) Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against infectious salmon anemia (ISA) and subsequent ISA virus infection. Vaccine, 29, 6392-401.
Published source details Lauscher A., Krossoy B., Frost P., Grove S., Konig M. & Bohlin J. (2011) Immune responses in Atlantic salmon (Salmo salar) following protective vaccination against infectious salmon anemia (ISA) and subsequent ISA virus infection. Vaccine, 29, 6392-401.
Actions
This study is summarised as evidence for the following.
| Action | Category | |
|---|---|---|
|
Use vaccinations Action Link |
 |
-
Use vaccinations
In 2011, a randomised, controlled study conducted in Norway (Lauscher et al., 2011) found that vaccinated salmon, Salmo salar, showed increased levels of survival after exposure to infectious salmon anaemia compared to an unvaccinated control group. Survival levels were lower with increasing strength of vaccine. After 45 days, mortality levels in the vaccinated groups were 55.0%, 28.3% and 10.0% respectively, for vaccines at strengths of 4%, 20% and 100%. Three groups were given one of three different strengths of vaccine at 100%, 20% and 4%. Two control groups were given a mock vaccine and saline. Six weeks after vaccination, all groups were infected with the infectious salmon anaemia virus and mortality was recorded daily for 45 days.
